vs

Side-by-side financial comparison of RADIAN GROUP INC (RDN) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

RADIAN GROUP INC is the larger business by last-quarter revenue ($300.5M vs $197.9M, roughly 1.5× REPLIGEN CORP). RADIAN GROUP INC runs the higher net margin — 51.5% vs 6.7%, a 44.8% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 2.7%). RADIAN GROUP INC produced more free cash flow last quarter ($115.7M vs $17.6M). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs -0.2%).

Radian Group Inc. is a mortgage insurance company with a suite of mortgage, risk, real estate, and title services.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

RDN vs RGEN — Head-to-Head

Bigger by revenue
RDN
RDN
1.5× larger
RDN
$300.5M
$197.9M
RGEN
Growing faster (revenue YoY)
RGEN
RGEN
+11.0% gap
RGEN
13.6%
2.7%
RDN
Higher net margin
RDN
RDN
44.8% more per $
RDN
51.5%
6.7%
RGEN
More free cash flow
RDN
RDN
$98.1M more FCF
RDN
$115.7M
$17.6M
RGEN
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
-0.2%
RDN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
RDN
RDN
RGEN
RGEN
Revenue
$300.5M
$197.9M
Net Profit
$154.8M
$13.3M
Gross Margin
52.5%
Operating Margin
76.2%
9.0%
Net Margin
51.5%
6.7%
Revenue YoY
2.7%
13.6%
Net Profit YoY
4.4%
143.9%
EPS (diluted)
$1.11
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RDN
RDN
RGEN
RGEN
Q4 25
$300.5M
$197.9M
Q3 25
$303.2M
$188.8M
Q2 25
$298.6M
$182.4M
Q1 25
$294.8M
$169.2M
Q4 24
$292.7M
$174.1M
Q3 24
$313.4M
$154.9M
Q2 24
$298.6M
$154.1M
Q1 24
$301.7M
$151.3M
Net Profit
RDN
RDN
RGEN
RGEN
Q4 25
$154.8M
$13.3M
Q3 25
$141.4M
$14.9M
Q2 25
$141.8M
$14.9M
Q1 25
$144.6M
$5.8M
Q4 24
$148.3M
$-30.3M
Q3 24
$151.9M
$-654.0K
Q2 24
$151.9M
$3.3M
Q1 24
$152.4M
$2.1M
Gross Margin
RDN
RDN
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
97.2%
50.0%
Q1 25
97.0%
53.6%
Q4 24
96.6%
26.1%
Q3 24
97.0%
50.0%
Q2 24
96.8%
49.8%
Q1 24
96.9%
49.5%
Operating Margin
RDN
RDN
RGEN
RGEN
Q4 25
76.2%
9.0%
Q3 25
65.5%
8.9%
Q2 25
58.6%
7.6%
Q1 25
63.9%
3.9%
Q4 24
83.6%
-17.7%
Q3 24
68.4%
-5.1%
Q2 24
63.0%
1.0%
Q1 24
65.8%
1.3%
Net Margin
RDN
RDN
RGEN
RGEN
Q4 25
51.5%
6.7%
Q3 25
46.7%
7.9%
Q2 25
47.5%
8.2%
Q1 25
49.0%
3.4%
Q4 24
50.7%
-17.4%
Q3 24
48.5%
-0.4%
Q2 24
50.9%
2.2%
Q1 24
50.5%
1.4%
EPS (diluted)
RDN
RDN
RGEN
RGEN
Q4 25
$1.11
$0.24
Q3 25
$1.03
$0.26
Q2 25
$1.02
$0.26
Q1 25
$0.98
$0.10
Q4 24
$0.97
$-0.55
Q3 24
$0.99
$-0.01
Q2 24
$0.98
$0.06
Q1 24
$0.98
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RDN
RDN
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$24.8M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$4.8B
$2.1B
Total Assets
$8.1B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RDN
RDN
RGEN
RGEN
Q4 25
$24.8M
$767.6M
Q3 25
$15.3M
$748.7M
Q2 25
$22.1M
$708.9M
Q1 25
$24.2M
$697.2M
Q4 24
$19.2M
$757.4M
Q3 24
$28.1M
$784.0M
Q2 24
$13.8M
$809.1M
Q1 24
$27.0M
$780.6M
Total Debt
RDN
RDN
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
RDN
RDN
RGEN
RGEN
Q4 25
$4.8B
$2.1B
Q3 25
$4.7B
$2.1B
Q2 25
$4.5B
$2.1B
Q1 25
$4.6B
$2.0B
Q4 24
$4.6B
$2.0B
Q3 24
$4.7B
$2.0B
Q2 24
$4.5B
$2.0B
Q1 24
$4.4B
$2.0B
Total Assets
RDN
RDN
RGEN
RGEN
Q4 25
$8.1B
$2.9B
Q3 25
$8.2B
$2.9B
Q2 25
$9.6B
$2.9B
Q1 25
$8.8B
$2.9B
Q4 24
$8.7B
$2.8B
Q3 24
$8.4B
$2.8B
Q2 24
$8.1B
$2.9B
Q1 24
$7.8B
$2.8B
Debt / Equity
RDN
RDN
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RDN
RDN
RGEN
RGEN
Operating Cash FlowLast quarter
$119.9M
$25.7M
Free Cash FlowOCF − Capex
$115.7M
$17.6M
FCF MarginFCF / Revenue
38.5%
8.9%
Capex IntensityCapex / Revenue
1.4%
4.1%
Cash ConversionOCF / Net Profit
0.77×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$-174.8M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RDN
RDN
RGEN
RGEN
Q4 25
$119.9M
$25.7M
Q3 25
$358.4M
$48.1M
Q2 25
$-713.3M
$28.6M
Q1 25
$67.8M
$15.0M
Q4 24
$-663.6M
$39.2M
Q3 24
$-237.9M
$49.3M
Q2 24
$-207.3M
$42.2M
Q1 24
$51.0M
$44.7M
Free Cash Flow
RDN
RDN
RGEN
RGEN
Q4 25
$115.7M
$17.6M
Q3 25
$357.6M
$43.4M
Q2 25
$-714.6M
$21.5M
Q1 25
$66.6M
$11.4M
Q4 24
$-665.1M
$33.6M
Q3 24
$-239.2M
$42.3M
Q2 24
$-208.3M
$37.4M
Q1 24
$49.5M
$36.4M
FCF Margin
RDN
RDN
RGEN
RGEN
Q4 25
38.5%
8.9%
Q3 25
117.9%
23.0%
Q2 25
-239.4%
11.8%
Q1 25
22.6%
6.8%
Q4 24
-227.3%
19.3%
Q3 24
-76.3%
27.3%
Q2 24
-69.8%
24.3%
Q1 24
16.4%
24.0%
Capex Intensity
RDN
RDN
RGEN
RGEN
Q4 25
1.4%
4.1%
Q3 25
0.3%
2.5%
Q2 25
0.4%
3.9%
Q1 25
0.4%
2.1%
Q4 24
0.5%
3.2%
Q3 24
0.4%
4.5%
Q2 24
0.4%
3.1%
Q1 24
0.5%
5.5%
Cash Conversion
RDN
RDN
RGEN
RGEN
Q4 25
0.77×
1.93×
Q3 25
2.53×
3.23×
Q2 25
-5.03×
1.92×
Q1 25
0.47×
2.57×
Q4 24
-4.47×
Q3 24
-1.57×
Q2 24
-1.36×
12.70×
Q1 24
0.34×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons